Regulation of murine protein C gene expression in vivo: Effects of tumor necrosis factor-α, interleukin-1, and transforming growth factor-β

Thrombosis and Haemostasis

Volumn 82, Issue 4, 1999, Pages 1297-1301

  Yamamoto, Koji ^a   Shimokawa, Takayoshi ^a   Kojima, Tetsuhito ^a   Loskutoff, David J ^b   Saito, Hidehiko ^a,c  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c Aichi Juridical Found for Blood D   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5A; BLOOD CLOTTING FACTOR 8A; INTERLEUKIN 1; MESSENGER RNA; PROCOAGULANT; PROTEIN C; SERINE PROTEINASE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; HUMAN; IN SITU HYBRIDIZATION; IN VIVO STUDY; INFLAMMATION; KIDNEY; LIVER; MALE GENITAL SYSTEM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TESTIS;

EID: 0032824727     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1614379     Document Type: Article

References (51)

1. Kisiel W. Human plasma protein C. Isolation, characterization and mechanism of activation by α-thrombin. J Clin Invest 1979; 64: 761-9.
2. Esmon CT. The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem 1989; 264: 4743-6.
3. Marlar RA, Kleiss AJ, Griffin JH. Mechanism of action of human activated protein C, a thrombin-dependent anticoagulant enzyme. Blood 1982; 59: 1067-72.
4. van Hinsbergh VWM, Bertina RM, van Wijngaarden A, van Tilburg NH, Emeiss JJ, Haverkate F. Activated protein C decreases plasminogen activator-inhibitor activity in endothelial cell conditioned medium. Blood 1985; 65: 444-51.
5. Sakala Y, Loskutoff DJ, Gladson CL, Hekman CM, Griffin JH. Mechanism of protein C-dependent clot lysis: role of plasminogen activator inhibitor. Blood 1986; 68: 1218-23.
6. Bajzar L, Manuel R, Nesheim ME. Purification and characterization of TAFI, a thrombin-activatable fibrinolysis inhibitor. J Biol Chem 1995; 270: 14477-84.
7. Seligsohn U, Berger A, Abend M, Rubin L, Attias D, Zivelin A, Rapaport SI. Homozygous protein C deficiency manifested by massive venous thrombosis in the newborn. N Engl J Med 1984; 310: 559-62.
8. Bovill EG, Bauer KA, Dickerman JD, Callas P, West B. The clinical spectrum of heterozygous protein C deficiency in a large new England kindred. Blood 1989; 73: 712-7.
9. Kurosawa-Ohsawa K, Kimura M, Kume-Iwaki A, Tanaka T, Tanaka S. Anti-protein C monoclonal antibody induces thrombus in mice. Blood 1990; 75: 2156-63.
10. Taylor FB, Chang A Jr, Esmon CT, D'Angelo A, Vigano-D'Angelo S, Blick KE. Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon. J Clin Invest 1987; 79: 918-25.
11. Gerson WT, Dickerman JD, Bovill EG, Golden E. Severe acquired protein C deficiency in purpura fulminans associated with disseminated intravascular coagulation: treatment with protein C concentrate. Pediatrics 1993; 91: 418-22.
12. Beckmann RJ, Shmidt RJ, Santerre RF, Plutzky J, Crabtree GR, Long GL. The structure and evolution of a 461 amino acid human protein C precursor and its messenger RNA, based upon the DNA sequence of cloned human liver cDNAs. Nucleic Acids Res 1985; 13: 5233-47.
13. Okafuji T, Maekawa K, Nawa K, Marumoto Y. The cDNA cloning and mRNA expression of rat protein C. Biochem Biophys Acta 1992; 1131: 329-32.
14. Jamison CS, McDowell SA, Marlar RA, Degen SJF. Developmental expression of protein C and protein S in the rat. Thromb Res 1995; 78: 407-19.
15. Yamamoto K, Loskutoff DJ. Extrahepatic expression and regulation of protein C in the mouse. Am J Pathol 1998; 153: 547-55.
16. He X, Shen L, Bjartell A, Malm J, Lilja H, Dahlback B. The gene encoding vitamin K-dependent anticoagulant protein C is expressed in human male reproductive tissues. J Histochem Cytochem 1995; 43: 563-70.
17. Esmon CT. The regulation of natural anticoagulant pathways. Science 1987; 235: 1348-52.
18. He X, Shen L, Bjartell A, Dahlback B. The gene encoding vitamin K-dependent anticoagulant protein S is expressed in multiple rabbit tissues as demonstrated by Northern blotting, immunocytochemistry and in situ hybridization. J Histochem Cytochem 1995; 43: 85-96.
19. Radtke K-P, Fernandez JA, Greengard JS, Tang WW, Wilson CB, Loskutoff DJ, Protein C inhibitor is expressed in tubular cells of human kidney. J Clin Invest 1994; 94: 2117-24.
20. Malm J, He X, Bjartell A, Shen L. Dahlback B. Synthesis of vitamin K-dependent protein S in the Leidig cells of human testis. Biochem J 1994; 302: 845-50.
21. Laurell M, Christensson A, Abrahamsson P-A, Stenflo J, Lija H. Protein C inhibitor in human body fluids. Seminal plasma is rich in inhibitor antigen deriving from cells throughout the male reproductive system. J Clin Invest 1992; 89: 1094-101.
22. Scarpati EM, Sadler JE. Regulation of endothelial cell coagulant properties: Modulation of tissue factor, plasminogen activator inhibitors, and thrombomodulin by phorbol 12-myristate 13-acetate and tumor necrosis factor. J Biol Chem 1989; 264: 20705-13.
23. Schleef RR, Bevilacqua MP, Sawdey M, Gimbrone MA Jr, Loskutoff DJ. Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type-1 plasminogen activator inhibitor. J Biol Chem 1988; 263: 5797-803.
24. Sawdey M, Podor TJ, Loskutoff DJ. Regulation of type 1 plasminogen activator inhibitor gene expression in cultured bovine aortic endothelial cells: induction by transforming growth factor-β lipopolysaccharide, and tumor necrosis factor-α. J Biol Chem 1989; 264: 10396-401.
25. Idell S, Kumar A, Zwieb C, Holiday D, Koenig KB, Johnson AR. Effects of TGF-β and TNF-α on procoagulant and fibrinolytic pathways of human tracheal epithelial cells. Am J Physiol 1994; 267: 693-703.
26. Sawdey MS, Loskutoff DJ. Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-α, and transforming growth factor-β. J Clin Invest 1991; 88: 1346-53.
27. 2 in sepsis: Studies in nonhuman primates after interleukin-1α administration and during lethal bacteremia. Blood 1995; 86: 1027-34.
28. Samad F, Yamamoto K, Pandey M, Loskutoff DJ. Elevated expression of transforming growth factor-β in adipose tissue from obese mice. Mol Med 1997; 3: 37-48.
29. Boswell JM, Yui MA, Burt DW, Delley VE. Increased tumor necrosis factor and IL-1β gene expression in the kidneys of mice with lupus nephritis. J Immunol 1988; 141: 3050-4.
30. Brennan DC, Yui MA, Wuthrich RP, Kelley VE. Tumor necrosis factor and IL-1 in New Zealand Black/White mice. Enhanced gene expression and acceleration of renal injury. J Immunol 1989; 143: 3470-5.
31. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factorα: Direct role in obesity-linked insulin resistance. Science 1993; 259: 87-91.
32. Yamamoto K, Loskutoff DJ. Fibrin deposition in tissues from endotoxin-treated mice correlates with decreases in the expression of urokinase-type but not tissue-type plasminogen activator. J Clin Invest 1996; 97: 2440-51.
33. Tada N, Sato M, Tsujimura A, Iwase R, Hashimoto-Gotoh T. Isolation and characterization of a mouse protein C cDNA. J Biochem 1992; 111: 491-5.
34. Tokunaga K, Taniguchi H, Yoda K, Shimizu M, Sakiyama S. Nucleotide sequence of a full-length cDNA for mouse cytoskeletal β-actin mRNA. Nucleic Acids Res 1986; 14: 2829.
35. Keeton M, Eguchi Y, Sawdey M, Ahn C, Loskutoff DJ. Cellular localization of type 1 plasminogen activator inhibitor messenger RNA and protein in murine renal tissue. Am J Pathol 1993; 142: 59-70.
36. Griffin J, Mosher D, Zimmerman T, Kleiss A. Protein C, an antithrombotic protein, is reduced in hospitalized patients with intravascular coagulation. Blood 1982; 60: 261-4.
37. Marlar RA, Endres-Brooks J, Miller C. Serial studies of protein C and its plasma inhibitor in patients with disseminated intravascular coagulation. Blood 1985; 66: 59-63.
38. Fijnvandraat K, Derkx B, Peters M, Bijlmer R, Sturk A, Prins MH, van Deventer SJH, ten Cate JW. Coagulation activation and tissue necrosis in meningococcal septic shock: severly reduced protein C levels predict a high mortality. Thromb Haemost 1995; 73: 15-20.
39. Nawroth PP, Stern DM. Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med 1986; 163: 740-5.
40. Dinarello CA. Interleukin-1 and interleukin-1 antagonism. Blood 1991; 77: 1627-52.
41. Emeis JJ, Kooistra T. Interleukin 1 and lipopolysaccharide induce an inhibitor of tissue-type plasminogen activator in vivo and in cultured endothelial cells. J Exp Med 1986; 163: 1260-6.
42. Bevilacqua MP, Schleef RR, Gimbrone MA Jr, Loskutoff DJ. Regulation of the fibrinolytic system of cultured vascular endothelium by interleukin 1. J Clin Invest 1986; 78: 587-91.
43. Conway EM, Rosenberg RD. Tumor necrosis factor suppresses transcription of the thrombomodulin gene in endothelial cells. Mol Cell Biol 1988; 8: 5588-92.
44. Lentz SR, Tsiang M, Sadler JE. Regulation of thrombomodulin by tumor necrosis factor-α: Comparison of transcriptional and posttranscriptional mechanisms. Blood 1991; 77: 542-50.
45. Nawroth PP, Handley DA, Esmon CT, Stern DM. Interleukin 1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity. Proc Natl Acad Sci USA 1986; 83: 3460-4.
46. Fischer E, Marano MA, Barber AE, Hudson A, Lee K, Rock CS, Hawes AS, Thompson RC, Lowry SF, Moldawer LL. Comparison between effects of interleukin-1α administration and sublethal endotoxemia in primates. Am J Pathol 1991; 261: 442-52.
47. Cybulsky MI, Chan MKW, Movat HZ. Biology of disease. Acute inflammation and microthrombosis induced by endotoxin, interleukin-1, and tumor necrosis factor and their implication in Gram-negative infection. Lab Invest 1988; 58: 365-78.
48. Kant KS, Pollak VE, Weiss MA, Glueck HI, Miller MA, Hess EV. Glomerular thrombosis in systemic lupus erythematosus: Prevalence and significance. Medicine 1981; 60: 71-86.
49. Viberti G, Wiseman MJ, Pinto JR, Messent J. Diabetic nephropathy. In: Kahn CR, Weir GC, editors, Joslin's Diabetes Mellitus. Philadelphia: Lea & Febiger, 1994; 691-737.
50. Moll S, Menoud PA, Fulpius T, Pastore Y, Takahashi S, Fossati L, Vassalli JD, Sappino AP, Schifferli JA, Izui S. Induction of plasminogen activator inhibitor type 1 in murine lupus-like glomerulonephritis. Kidney Int 1995; 48: 1459-68.
51. Yamamoto T, Noble NA, Cohen AH, Nast CC, Hishida A, Gold LI, et al. Expression of transforming growth factor β is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci USA 1993; 90: 1814-8.